CSIMarket


Bicycle Therapeutics Plc  (BCYC)
Other Ticker:  
 

Bicycle Therapeutics Plc

BCYC's Fundamental analysis








Looking into Bicycle Therapeutics Plc growth rates, revenue grew by 298.9 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 57

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.31 %

Bicycle Therapeutics Plc net loss deacreased by in I. Quarter 2024 year on year, Bicycle Therapeutics Plc net loss increased by -32 % in I. Quarter 2024 year on year,

More on BCYC's Growth


Bicycle Therapeutics Plc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 5.99 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 23.56.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.31.


More on BCYC's Valuation
 
 Total Debt (Millions $) 31
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 8.37

Bicycle Therapeutics Plc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 5.99 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 23.56.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.31.

Bicycle Therapeutics Plc Price to Book Ratio is at 2.75 lower than Indusry Avg. of 74.58. and higher than S&P 500 Avg. of 0.01

More on BCYC's Valuation

  Market Capitalization (Millions $) 980
  Shares Outstanding (Millions) 43
  Employees -
  Revenues (TTM) (Millions $) 42
  Net Income (TTM) (Millions $) -168
  Cash Flow (TTM) (Millions $) 164
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) 31
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 8.37

  Market Capitalization (Millions $) 980
  Shares Outstanding (Millions) 43
  Employees -
  Revenues (TTM) (Millions $) 42
  Net Income (TTM) (Millions $) -168
  Cash Flow (TTM) (Millions $) 164
  Capital Exp. (TTM) (Millions $) -1





  Ratio
   Capital Ratio (MRQ) 10.42
  Total Debt to Equity (MRQ) 0.09
  Tangible Leverage Ratio (MRQ) 0.51
  Asset Turnover Ratio (TTM) 0.08
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com